Chronic Kidney Disease: A Case Series

Author:

Gupta Girish,Gupta Naveen,Pandey Dileep,Gupta Gaurang

Abstract

Chronic renal failure (CRF) is a progressive and  irreversible deterioration of renal functions. Diabetes,  hypertension, indiscriminate use of antibiotics and  non-steroidal anti-inflammatory drugs (NSAIDs)  are major contributory factors of chronic kidney  disease (CKD) or end stage renal disease (ESRD). (1,2) In modern system, the role of medicinal treatment  is very limited while haemo or peritoneal dialysis  is cumbersome and expensive. Economic and  legal issues limit the possibility of renal transplant  and depends on the availability of donor.(3) On the  other hand, homoeopathic treatment, if sought at  an early stage, can help in maintaining or to some  extent reviving renal functions by lowering serum  creatinine thereby improving GFR. Gupta et. al. has  done some work on the medicinal treatment of this  difficult disease and have published the results.(4) 

Publisher

ACS Publisher

Reference15 articles.

1. Jha V. Current status of end-stage renal disease care in India and Pakistan. Kidney International

2. Supplements 2013; (3): 157-160; doi: 10.1038/ kisup.2013.3. (http://www.nature.com/kisup/journal/ v3/n2/full/kisup20133a.html).

3. Indian Council of Medical Research, New Delhi. Study on causes of death by verbal autopsy of India 2011; (http://icmr.nic.in/final/causes_death/causes_ death.htm) (accessed 11 December 2011).

4. Chugh KS, Jha V, Chugh S. Economics of dialysis and renal transplantation in the developing world. Transplant Proc 1999; (31): 3275-3277.

5. Gupta G, Gupta N, Pandey D, Gupta G. A clinical study on the role of homoeopathic medicines in chronic renal failure patients assessed by estimated glomerular filtration rate (eGFR). National Journal of HomoeopathyJun 2015 (189thissue); 17(6): 14-29.

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3